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non-toxic manner of amyloid structures
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specialized cells.
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Accumulation of toxic amyloid oligomers is a key
feature in the pathogenesis of amyloid-related dis-
eases. Formation of mature amyloid fibrils is one
defense mechanism to neutralize toxic prefibrillar
oligomers. This mechanism is notably influenced by
apolipoprotein E variants. Cells that produce mature
amyloid fibrils to serve physiological functions must
exploit specific mechanisms to avoid potential accu-
mulation of toxic species. Pigment cells have tuned
their endosomes to maximize the formation of func-
tional amyloid from the protein PMEL. Here, we
show that ApoE is associated with intraluminal vesi-
cles (ILV) within endosomes and remain associated
with ILVs when they are secreted as exosomes.
ApoE functions in the ESCRT-independent sorting
mechanism of PMEL onto ILVs and regulates the en-
dosomal formation of PMEL amyloid fibrils in vitro
and in vivo. This process secures the physiological
formation of amyloid fibrils by exploiting ILVs as
amyloid nucleating platforms.
INTRODUCTION
Amyloids oligomers and fibrils are broadly associated with
various diseases including Alzheimer disease (AD) among
others (Harrison et al., 2007). Yet, the process of amyloid forma-
tion and the role they play in the physiopathology of disease
remains unclear. Of interest, there is accumulating evidence
for the involvement of endosomal compartments in amyloid
homeostasis (Thinakaran and Koo, 2008). In particular, amyloi-
dogenic proteins and peptides accumulate in multivesicular en-dosomes (MVEs) and aggregate as toxic oligomers (Takahashi
et al., 2002). These endosomal aggregates cause neuronal lysis
(D’Andrea et al., 2001) that contributes to the release of toxic
species into the extracellular space (Haass and Selkoe, 2007).
A cell defense mechanism to neutralize these toxic species is
their incorporation into more inert mature amyloid fibrils (Haass
and Selkoe, 2007). The fibrillation process is notably influenced
by lipoparticles containing the apolipoprotein E (ApoE) (Kane-
kiyo et al., 2014), variants of which are major genetic risk factors
for AD.
Yet, not all amyloids are associated with disease as so-
called ‘‘functional’’ amyloids (Fowler et al., 2007) serve physio-
logical roles. The best studied example of functional amyloids
in mammals is amyloid fibrils produced from amyloidogenic
fragments of the premelanosomal protein (PMEL) in pigment
cells (Watt et al., 2013). These amyloid fibrils serve as a scaf-
fold on which melanins polymerize within lysosome-related
organelles called melanosomes (Raposo and Marks, 2007).
The unique mechanisms exploited by pigment cells to avoid
accumulation of potentially toxic amyloidogenic fragments of
PMEL in MVEs remain elusive (Watt et al., 2011, 2013). Yet,
the sorting of PMEL amyloidogenic fragments to intraluminal
membrane vesicles (ILVs) seem crucial to induce their aggrega-
tion into inert ‘‘functional’’ amyloid fibrils (van Niel et al., 2011).
During this process, the PMEL lumenal amyloidogenic frag-
ment is released by a beta-secretase BACE-2-mediated cleav-
age (Rochin et al., 2013) from a C-terminal fragment (CTF)
(Kummer et al., 2009; van Niel et al., 2011) and, within the
same MVE, is sorted to the intraluminal vesicles (ILVs) by an
endosomal sorting complex required for transport (ESCRT)-
independent/CD63-dependent mechanism (van Niel et al.,
2011). Here, we show that ILVs of MVEs function as nucleating
platforms for amyloid fibrillogenesis, and ApoE at the mem-
brane of ILVs plays a pivotal role in PMEL sorting and in the
formation of PMEL fibrils.Cell Reports 13, 43–51, October 6, 2015 ª2015 The Authors 43
Figure 1. Identification and Characterization of Exosomes from MNT-1 Cells
(A) Lysates (L) and exosomes (E) isolated from medium of MNT-1 cells were analyzed by western blot for CD63, PMEL luminal domain full length (a-PMEL-Nter),
and PMEL amyloidogenic fragment (I51).
(B) Exosomes fromMNT-1 were immunolabeled with antibodies against PMEL amyloidogenic fragment (I51), revealed with Protein A gold particles (PAG) of 5 nm
diameter and observed by EM.
(C–H) Analysis of exosomes by cryo-EM. (C and D) Exosomes purified fromMNT-1 cells culture media. Some exosomes are covered by a cap made of a stack of
layers (white arrows). (E) Fourier transform of the stack of layers observed in (D) showing diffraction spots at 1/3.5 nm. (F) Exosomes purified from HeLa cells.
(G and H) 3D reconstruction of MNT-1 exosomes by cryotomography and corresponding 3D model.
(I) The presence of ApoE, CD63, and Tsg101 in equivalent amount of exosomes fromMNT-1 and HeLa cells was determined fromwestern blot analysis (shown in
Figure S1H) and their enrichment in MNT-1-derived exosomes was quantified and normalized to their enrichment in exosomes from HeLa cells without cap.
(J) Human Plasma (HP), lysates (L) and exosomes (E) from MNT-1 cells were analyzed by western blot for ApoE, ApoA1, and ApoB.
(K) Exosomes from MNT-1 were co-immunolabeled with antibodies against PMEL amyloidogenic fragment (I51, PAG 15) and ApoE (PAG 10).
See also Figure S1.RESULTS
Exosomes fromPigment Cells Are Associatedwith ApoE
Lipoparticles
To better understand the involvement of ILVs in the formation of
amyloids, we first investigated the fraction of ILVs secreted as
exosomes from pigment cells. Exosomes are extracellular ILVs
that are released after the fusion of MVEs with the plasma mem-
brane (Raposo and Stoorvogel, 2013). They are enriched in spe-
cific sets of lipids, proteins, and RNAs and provide details on key44 Cell Reports 13, 43–51, October 6, 2015 ª2015 The Authorsprocesses in MVEs from which they originate. Exosomes iso-
lated from culture medium of human melanocytic cell line
MNT-1 contained the tetraspanin CD63 that is commonly en-
riched in MVEs and exosomes. The exosome pellet also con-
tained processed and full-length amyloidogenic luminal domain
of PMEL (Figure 1A) and the PMEL CTF and the melanosomal
protein MART-1 (Figure S1A). The distinct intra-endosomal traf-
ficking of PMEL CTF and luminal domain (van Niel et al., 2011)
and the absence of interaction between both fragments (Fig-
ure S1B) indicated that the PMEL luminal domain is likely
associated with exosomes after release from the CTF. By immu-
noelectron microscopy (IEM), the processed PMEL amyloido-
genic domain associated as aggregates with the outer
membrane of 100–150 nm vesicles (Figure 1B). These observa-
tions suggested that these exosomes are the extracellular coun-
terpart to the ILVs upon which PMEL amyloid fibrils formed
within MVEs. We next analyzed MNT-1 exosomes at high reso-
lution by cryoelectron microscopy (cryo-EM). Exosomes ap-
peared as a population of spherical vesicles of 120 nm diameter
on average with few larger vesicles as previously reported
(Brouwers et al., 2013; Ji et al., 2013). The vesicles displayed
two layers of electronic densities 3.5–4 nm apart, corresponding
to each leaflet of the lipid bilayer and were covered by darker
densities that correspond to membrane proteins (Figure 1C).
Surprisingly, 10% of MNT-1 exosomes exhibited a ‘‘cap’’ con-
sisting of a stack of horizontal layers (Figures 1C and 1D). Most
caps were rectangular by thin section but some were conical
(Figures S1D and S1E) and their dimensions range between
12–38 nm in height and 30–100 nm in width (Figures 1C and
S1C–S1E). The number of layers varied from 4 to 12, but the dis-
tance between each layer was constant to 3.5 nm, as shown by
the diffraction spots present in the Fourier transform (Figure 1E,
inset). Analysis of the exosomes by cryotomography revealed
that the caps had a closed cylindrical shape in three dimensions
(Figures 1G and 1H). Such caps were also observed on exo-
somes from primary melanocyte cells but not on exosomes
from HeLa (Figure 1F) and other cell types (Figure S1F).
The stacked layers and spacing of the MNT-1 exosome caps
were strikingly reminiscent of low-density lipoproteins consisting
of apolipoproteins and cholesterol forming a striated core with
layers spaced by 30–35 A˚ and observed by cryo-EM (Orlova
et al., 1999). Using quantitative mass spectrometry (SILAC) we
compared exosomes derived from either unlabeled MNT-1 cells
or HeLa cells cultured in heavy media. In the genome ontology
(GO) term 0034358 ‘‘Plasma lipoprotein particle,’’ only human
ApoE was found statistically enriched in exosomes derived
fromMNT-1 (enrichment factor: 4.30, p value = 1.08e-03, 25 spe-
cific peptides with a coverage >61%) in agreement with endoge-
nous expression ofAPOE in pigment cell type (Ishida et al., 2004).
Western blot analysis of exosomes released from MNT-1 cells
further shows that ApoE was enriched (Figures 1I and S1G) and
that apolipoproteins A1 and B were absent (Figure 1J), excluding
potential contamination by plasma lipoparticles. Moreover, floa-
tation of exosomes on sucrose gradient showed that ApoE was
only present in the fraction containing exosome-associated pro-
teins, thereby excluding free ApoE or ApoE-lipoparticles in the
exosomal pellet (Figure S1H). Using cryo-EM and immunogold
labeling we strengthen the findings that ApoE is associated with
exosomes (Figure 1L). Immunogold labeling on aldehyde-fixed
exosomes highlights the co-localization of ApoE on the outer
membrane of exosomes with CD63 (Figure S1I) and PMEL fibrils
(Figure1K). Similar observationsweredoneonexosomesderived
from human primary melanocytes (Figures S1J and S1K).
EndogenousApoECo-localizes and Interactswith PMEL
on ILVs of Endosomes
The endosomal origin of exosomes led us to investigate whether
ApoE is present within MVEs. Endogenous ApoE was detectedby western blotting of lysates of MNT-1 cells grown in lipopro-
tein-depleted human serum (LPDS) and was significantly
reduced after treatment with ApoE-specific small interfering
RNA (siRNA) (Figure 2A). By immunofluorescence microscopy,
labeling for PMEL and ApoE partially overlapped in post-Golgi
compartments of MNT-1 cells grown in LPDS (Figure 2B), and
IEM analyses detected ApoE in MVEs and in early stage melano-
somes containing PMEL-derived fibrils (Figure 2C). The associa-
tion of ApoE with ILVs was confirmed by cell fractionation on
sucrose gradients, in which CD63, PMEL amyloidogenic frag-
ments, and ApoE were enriched in a fraction of similar density
to that of exosomes (Figure S2A, fraction 3). IEM analysis of
this fraction revealed membrane vesicles enriched in CD63 (Fig-
ures 2D and 2E) that were of similar diameter and orientation as
the exosomes described above. These ILVs associated with
PMEL fibrils (Figures 2D and S2B) and ApoE-positive structures
(Figures 2E and 2F). The co-localization of ApoE and PMEL on
ILVs was consistent with their co-immunoprecipitation using
antibodies against the luminal domain and amyloidogenic region
of PMEL (Figure 2G). These data indicate that ApoE is associated
with the PMEL amyloid luminal domain and PMEL fibrils at the
surface of ILVs within MVEs.
ApoE Regulates PMEL Amyloid Fibrils Formation
The reported role of ApoE in pathological amyloidogenesis (Ka-
nekiyo et al., 2014) prompted us to investigate the capacity of
ApoE to regulate PMEL fibrillogenesis within MVEs of MNT-1
cells. Depletion of endogenous ApoE by siRNA, but not of exog-
enous ApoE using LPDS (Figure 3A), strongly reduced both the
formation of epitopes associated with amyloid fibrils (Figure 3A)
and the accumulation of PMEL fibrils in unpigmented stage II
melanosomes observed by EM (Figures 3B and 3C). Instead of
forming structured fibrils, the PMEL luminal domain in ApoE
siRNA-treated cells accumulated as unstructured aggregates
within vacuolar structures (Figures S3A and S3B). Consequently,
relative to control cells the number of stage III and IV melano-
somes with melanin pigments deposited along the fibrils (Seiji
et al., 1963) was reduced and aberrant multilamellar structures
with irregular lumenal pigment deposits appeared (Figures 3B
and 3C, noted ‘‘APM,’’ and S3A). Despite the alteredmorphology
of melanosomes, ApoE siRNA did not affect total melanin con-
tent (Figure S3C), suggesting that the effect was uniquely asso-
ciated to amyloid fibril formation and not melanin synthesis.
Similar impairment of generation of PMEL fibrils within early me-
lanosomes was also observed after depletion of endogenous
ApoE in human primary melanocytes (Figures 3D and 3E).
To testwhether ApoEdepletion affectsPMELamyloidogenesis
in a physiological context, we analyzedmelanosomemorphology
inpigment cells inAPOE/mice.Compared tocontrolC57BL/6J
mice (wild-type [WT]),APOE/mice did not display any obvious
coat color defect (Figure S4A) as reported in PMEL/mice (Hell-
stro¨m et al., 2011). Because of potential compensatory effects
observed in skin melanocytes of mice with melanogenesis de-
fects (Lopes et al., 2007), we focused on retinal pigment epithe-
lium (RPE) in which the compensatory effect is less apparent.
Whereas, melanosomes in the RPE of control mice were charac-
teristically ellipsoidal, melanosomes of APOE/ mice were
rounder (Figures 4A and 4C), but neither larger nor fewer inCell Reports 13, 43–51, October 6, 2015 ª2015 The Authors 45
Figure 2. Endosomal Localization of ApoE
(A) Whole cell lysates of MNT-1 cells that were
cultured in the presence of human serum (HS) or
lipoprotein-depleted human serum (LPDS) and
treated with control siRNA or ApoE siRNA were
analyzed by western blot using an anti-ApoE
antibody or anti-b-tubulin antibody as a loading
control.
(B) MNT-1 cells cultured in LPDSwere analyzed by
IFM after labeling for PMEL luminal domain (Nki)
and ApoE; arrows point to co-localization spots.
(C) Ultrathin cryosections of MNT-1 cells were
double immunogold labeled for PMEL luminal
domain (Nki, PAG 10) and ApoE (PAG 15). Arrows
indicate ApoE labeling in unpigmented early
melanosomes (UM).
(D–F) Fraction 3 obtained from cell fractionation of
MNT-1 cells on sucrose gradients (Figure S2A)
was observed by electron microscopy after im-
munogold labeling with antibodies against (D)
PMEL luminal domain (Nki, PAG 15) and CD63
(PAG 10), (E, inset) ApoE (PAG 15) and CD63 (PAG
10), or (E, inset) ApoE (PAG 15) and PMEL amy-
loidogenic fragment (I51 PAG 5).
(G) TX-100 lysates of MNT-1 cells were immuno-
precipitated with isotype control antibody or anti-
bodies specific to PMEL luminal domain full length
(a-PMEL-Nter) and PMEL amyloidogenic frag-
ment (I51) as indicated. Immunoprecipitates (IP) or
untreated lysate (Input) were analyzed by western
blot with a Pmel-N (top) or anti-ApoE antibody
(bottom).
See also Figure S2.number (FiguresS4B andS4C). The round shape is characteristic
of a defect in PMEL-derived amyloidogenesis as observed in
PMEL/ mice (Hellstro¨m et al., 2011). Importantly, overexpres-
sion of human APOE3 isoform, and to a lesser extent of human
APOE4 isoform, rescued the phenotype of APOE/ mice (Fig-
ures 4B and 4C). In vivo, ApoE- and PMEL-positive labeling
were also observed in MVEs of RPE likely corresponding to early
stagemelanosomes (see electronmicrographs in Figures 4D, 4E,
andS4D) andonextracellular vesicles thatwereby their size remi-
niscent of exosomes in the vicinity of RPE cells (Figures 4F and
S4E). These data indicate that ApoE is associated with ILVs and
exosomes and is required for PMEL amyloidogenesis and conse-
quently melanosome maturation in vivo.
ApoE Is Involved in the CD63-Dependent/ESCRT-
Independent Sorting of PMEL
The defects in melanosome morphology observed in ApoE-defi-
cient melanocytes are reminiscent of those observed when46 Cell Reports 13, 43–51, October 6, 2015 ª2015 The AuthorsPMEL cleavage or sorting is defective
(Rochin et al., 2013; van Niel et al.,
2011). Impaired formation of PMEL fibri-
logenesis upon ApoE deficiency is not
due to a defect of PMEL cleavage since
ratio between proteolytic PMEL frag-
ments remained unchanged after ApoE
depletion (Figure S5A); but it could belinked to PMEL sorting to ILVs since siRNA-mediated depletion
of ApoE reduced the association of ApoE and PMEL luminal
domain to ILVs that are released as exosomes (Figure 5A). This
defect of PMEL sorting in ApoE-depleted cells echoed the ob-
servations made upon depletion of CD63, which regulates the
ESCRT-I-independent sorting of the PMEL luminal domain on
ILVs (van Niel et al., 2011). In agreement with a role of ApoE
and CD63 in the same sorting pathway, partial siRNA-mediated
depletion of CD63 (Figure S5B) induced a significant accumula-
tion of ApoE in a perinuclear compartment (Figure 5B) that we
identified by EM as the Golgi apparatus (Figure 5C). In contrast,
depletion of the ESCRT-I subunit TSG101 (Figure S5B) induced
an accumulation of ApoE and PMEL in the lumen of enlarged en-
dosomes with irregular internal membranes (Figures S5C and
S5D). As a potential consequence of impaired endosomal
trafficking of ApoE, depletion of CD63, but not of ESCRT-I, in-
hibited the targeting of ApoE to ILVs secreted as exosomes (Fig-
ure 5D) and the co-immunoprecipitation of PMEL with ApoE
Figure 3. ApoE in the Fibrillogenesis of
PMEL in Cell Line
(A) Whole cell lysates of MNT-1 cells that were
cultured in HS or LPDS and treated with either
control siRNA or different ApoE siRNA were
analyzed by western blot with anti-ApoE antibody
or anti-b-tubulin antibody as a loading control.
Corresponding Triton X-100-insoluble fraction
from MNT-1 cells were analyzed by western blot
using fibrils-specific antibody HMB45.
(B) Quantification of the number of different en-
dosomal/melanosomal compartments, as indi-
cated on the x axis and defined by morphology,
observed by conventional EM in MNT-1 cells that
were treated as indicated. Values represent the
percentage of each compartment (±SD) relative to
all of the endosomal/melanosomal compartments
identified in 20 cell profiles per condition (***p <
0.01, **p < 0.02, *p < 0.05).
(C) Control cells cultured in HS and LPDS or in
ApoE-depleted cells cultured in LPDS observed
by conventional EM. Labels II, III, and IV, indicate
the different stages of maturation of melano-
somes; UA, unstructured aggregates; APM,
aberrant pigmented melanosomes.
(D) Whole cell lysates of human primary melano-
cytes that were treatedwith either control siRNA or
ApoE siRNA were analyzed by western blot with
anti-ApoE antibody or anti-b-tubulin antibody as a
loading control. Corresponding Triton X-100
insoluble fractions were analyzed by western blot
using fibrils-specific antibody HMB45.
(E) Control and ApoE-depleted human primary
melanocytes were observed by conventional EM.
Arrows indicate unpigmented early melanosomes
that are devoid of PMEL fibrils after ApoE
depletion.
See also Figure S3.(Figure S5E). By contrast, inhibition of sphingomyelinase—that
inhibits ESCRT-independent ILV formation in glial cells (Trajkovic
et al., 2008) but not PMEL sorting (van Niel et al., 2011)—did not
impair ApoE association with exosomes (Figure S5F), indicating
that ApoE sorting to ILVs is ceramide-independent. Our results
show that ApoE is a downstream effector of the ESCRT-
independent/CD63-dependent sorting of PMEL that regulates
PMEL amyloidogenesis.
DISCUSSION
Here, we show that the binding of ApoE to themembrane of exo-
somes and ILVs is a major regulator of PMEL amyloid fibrils for-
mation during melanogenesis. This ascertains APOE as a newCell Reports 13, 43–5pigmentation gene, in agreement with
the regulation of its expression by MITF,
a master regulator of melanocyte devel-
opment (Hoek et al., 2008). As with other
genes required for early steps of melano-
genesis (Hellstro¨m et al., 2011), APOE
might have been missed because its
disruption causes only minor coat coloralterations and no visual defect (Mak et al., 2014) due to potential
compensatory mechanisms.
ApoE is an amphipathic protein (Segrest et al., 1992) that
could interact both with membranes of ILVs and with the
PMEL luminal domain during the processes of sorting and fibril-
lation. This suggests that ApoE could act as a loading device on
ILVs for shed PMEL luminal domain providing a mechanism for
the CD63-dependent/ESCRT-independent sorting pathway of
PMEL (van Niel et al., 2011). The involvement of CD63 in
ESCRT-independent ILVs formation in a cervical cancer cell
line (Edgar et al., 2014) and the potential presence of ApoE in
exosomes secreted by other cell types such as oligodendro-
cytes (Conde-Vancells et al., 2008; Kra¨mer-Albers et al., 2007)
suggests a widespread mechanism where ApoE could act as a1, October 6, 2015 ª2015 The Authors 47
Figure 4. ApoE in the Fibrillogenesis of
PMEL In Vivo
(A) RPE sections from APOE+/+ (left) and APOE/
mice (right) were analyzed by conventional EM.
Note the ellipsoidal melanosomes (M) in RPE of
APOE+/+ mice and their rounder shapes in the RPE
of APOE/ mice.
(B) RPE sections from APOE3 (left) and APOE4
Knockin mice (right) were analyzed by conven-
tional EM. Note the ellipsoidal melanosomes (M) in
both RPE.
(C) The ratio between maximum width and length
of an average of 300 melanosomes per conditions
was measured using ITEM software.
(D–F) Ultrathin cryosections of RPE from APOE3
and APOE4 KI mice were double immunogold-
labeled for PMEL luminal domain (HMB45, PAG
10) and ApoE (PAG 15). (D and E) Arrows indicate
ApoE labeling in MVE and unpigmented early
melanosomes (UM). (F). Arrows indicate extracel-
lular vesicles labeled for PMEL and ApoE in the
vicinity of RPE (***p < 0.01, **p < 0.02, *p < 0.05).
See also Figure S4.general loading mechanism for soluble proteins or shed luminal
domains of endosomal transmembrane proteins. ApoE could
also create specific regions on the membrane of ILVs and exo-
somes, as shown by cryo-EM that would cluster important co-
factors of fibrillation. Among them, specific lipids, such as
ganglioside or cholesterol, have already been reported as regu-
lators of amyloidogenesis processes at the surface of exosomes
(Yuyama et al., 2014). In view of the differential level of rescue of
PMEL amyloidogenesis by APOE3 and APOE4 expression
in vivo, the investigation of the influence of APOE isoforms on
such processes would be of interest.
Moreover, our data suggest that the presence of ApoE in en-
dosomes is one of the specific mechanisms that pigment cells
use to avoid potential toxicity inherent to PMEL amyloidogene-
sis. Within MVEs, ApoE enables ILVs to nucleate newly shed
PMEL prefibrillar species (Watt et al., 2011) into mature amyloid48 Cell Reports 13, 43–51, October 6, 2015 ª2015 The Authorsfibrils. By acting directly at the site of
production of PMEL-derived amyloid
peptides, ApoE would prevent the accu-
mulation of potentially toxic PMEL-
derived amyloid peptides. Interestingly,
the neural crest origin of melanocytes
and the analogies of trafficking and pro-
cessing pathways between PMEL and
APP strengthen the relevance of this pro-
cess for amyloid formation in AD. In this
context, however, the major expression
of ApoE and Ab by distinct cell types, as-
trocytes and neurons, respectively (Xu
et al., 2006), prevents similar process as
ApoE and Ab would mainly encounter
in the extracellular medium. It is then
tempting to speculate, as observed sepa-
rately for exosomes (Yuyama et al., 2014)
and ApoE (Li et al., 2012), that exosomesharboring ApoE would favor endocytosis and targeting of Ab to
MVEs and provide a favorable environment for Ab seeding and
neutralization (Hu et al., 2009).
The association of ApoE with ILVs and exosomes ascertains
a new pathway of secretion for ApoE that would differ from its
typical release as phospholipid discs (Kockx et al., 2008). The
association of ApoE with ILVs would also extend the properties
of exosomes as ApoE binds specific receptors for uptake
and modulates the activity of soluble ApoE receptors (Rebeck
et al., 2006). This association also prompts us to reconsider
the respective roles of ApoE and exosomes in several pigment
cell-associated pathologies such as age-related macular
degeneration (Johnson et al., 2011; Wang et al., 2009)
and melanoma metastasis (Peinado et al., 2012; Pencheva
et al., 2012) where ApoE may endow signaling properties to
exosomes.
Figure 5. ApoE in CD63-Dependent Sorting
of PMEL
(A) Top: exosomes from MNT-1 cells that were
cultured in HS or LPDS and treated with
control siRNA or ApoE siRNA were analyzed by
western blot with anti-CD63, anti-ApoE, and anti
PMEL luminal domain (a-PMEL-Nter antibody).
Bottom: relative enrichment of ApoE and PMEL
luminal domain was quantified and results are
expressed as the mean ± SD of three experiments
(***p < 0.01).
(B) MNT-1 cells in LPDS and treated with CD63
siRNA were analyzed by IFM after labeling for
CD63 and ApoE. White stars indicate CD63-in-
activated cells; we purposely show an experiment
in which CD63 depletion was lower than normal to
emphasize the differences between cells that do
and do not express CD63. Scale bar, 10 mm.
(C) Ultrathin cryosections of MNT-1 cells that were
cultured in LPDS and treated with control siRNA
(top) or CD63 siRNA (bottom) were double im-
munogold labeled for PMEL luminal domain (Nki,
PAG 10) and ApoE (PAG15).White arrows indicate
ApoE labeling in unpigmented melanosomes and
black arrows indicate ApoE-labeling in Golgi
stack.
(D) Exosomes secreted by MNT-1 cells that were
cultured in LPDS and treated with control siRNA,
CD63 siRNA, or tsg101 siRNA were analyzed by
western blot with anti-CD63, anti-ApoE, and or
anti-b-tubulin antibody as a loading control. Right:
relative enrichment of ApoE was quantified and
results are expressed as the mean ± SD of three
experiments (**p < 0.02).
See also Figure S5.EXPERIMENTAL PROCEDURES
Mice
MaleAPOE/mice (n = 3) andmale C57/bl6/J (n = 3) were purchased from the
Maastricht University. Mice were 12 weeks of age when sacrificed. Until sac-
rifice, mice were housed in cages with free access to water and regular chow
diet (AB diets, Woerden).APOE3 andAPOE4 targeted replacement mice (n = 2
each) were purchased from Taconic Europe A/S Lille Skensved. Mice were
12 weeks of age when sacrificed. Until sacrifice, mice were housed in cages
with free access to water and regular chow diet (irradiated A4 from Safe-
Diet). Before collecting all required tissues, mice were perfused with a sterile
saline solution (150 mM saline, 2.5 mM CaCl2 in HEPES, pH 7.3) via the left
ventricle. The eyes (enucleated and extraocular muscles were cut) were
dissected and harvested in modified Karnovsky’s fixative (2% paraformalde-
hyde/2% glutaraldehyde/0.1 m cacodylate buffer, pH 7.3/0.06% CaCl2). After
a few hours, eyes and skin were sectioned and fixed overnight at 4C in modi-
fied Karnovsky’s fixative. The experimental animal committee of the Maas-
tricht University approved this animal experiment.
Cell Culture, Drug Treatment, Transfection, and siRNA Depletion
Humanmelanocytic MNT1 cells were maintained as previously described (van
Niel et al., 2011). When indicated, fetal bovine serum was replaced by human
serum and lipoprotein-depleted human serum (Millipore). Cells were treated
for 24 hr with 2.5 mM GW4869 (Sigma). MNT1 cells were transfected with
siRNA duplex oligonucleotides as reported previously (van Niel et al., 2011).
Cells were subjected to one round of siRNA transfection and collected after
72 hr. MNT-1 cells were transfected with plasmid constructs using Lipofect-
amine 2000 (Invitrogen) following the manufacturer’s recommendations and
cells were collected and analyzed after 48 hr. For the rescue experiment, cellswere subjected to two rounds of siRNA transfection against ApoE and after
72 hr cells were transfected with plasmid constructs for ApoE3 and collected
after 24 hr.
Exosome Isolation
Exosomes were prepared from conditioned media incubated for 48 hr on sub-
confluent cells. Media were centrifuged at 2,0003 g for 15min (4C) and 4,000
3 g (15 min, 4C) to remove debris. Next, the supernatant was centrifuged at
10,000 3 g for 30 min (4C) and exosomes were collected from the superna-
tant by centrifugation at 100,000 3 g for 60 min (4C). The pellet was resus-
pended and washed in PBS (pH 7).
Immunoprecipitation
MNT1 cells were lysed directly in lysis buffer (20 mM Tris, 150 mM NaCl, 1%
Triton X-100, 1 mM EDTA [pH 7.2]) with protease inhibitor cocktail (Roche).
After 30 min at 4C, insoluble material was removed by centrifugation at
12,0003 g and cell lysatewas precleared for 30min by addition of 50 ml protein
G-Agarose beads (Invitrogen) and for 30 min by addition of 50 ml protein
G-Agarose beads coated with irrelevant rabbit antibody (Dako). Proteins
were then immunoprecipitated by adding 50 ml protein G-Agarose beads
coated with antibodies in MNT-1 lysates and by adding 50 ml protein
G-Agarose beads coated with specific antibody for anti-ApoE antibody in
HeLa cell lysates. After 2 hr at 4C under constant agitation, beads were
washed five times in lysis buffer. The immunoprecipitates were subjected to
western blot analysis as described below.
Western Blot
Triton X-100 soluble and insoluble material from MNT-1 cells was obtained as
previously described (van Niel et al., 2011) and analyzed by western blot asCell Reports 13, 43–51, October 6, 2015 ª2015 The Authors 49
described in van Niel et al. (2011). Signal intensities were quantified with
ImageJ software.
Electron Microscopy
Tissues from APOE/ mice and wild-type mice and MNT-1 cells were fixed
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for conventional EM anal-
ysis. Tissue and cells were processed for Epon embedding and ultrathin sec-
tions and then contrasted with uranyl acetate and lead citrate as described
(Lopes et al., 2007). For ultrathin cryosectioning and immunogold labeling,
samples were processed and analyzed as reported previously (van Niel
et al., 2011).
Cryoelectron Microscopy
A glow-discharged lacey Formvar copper grid (Ted Pella) was loaded with 5 ml
of exosome solution. Next, the solution was blotted and vitrified in liquid
ethane by plunge freezing. Images were recorded under low-dose conditions
with a FEI CM120 operating at 120 kV with a SSDGATAN 1 k3 1 k camera at a
magnification of 35,000 resulting in 4.96 A˚/pixel. The intended underfocus was
set to 1.5 to 2 mm. Cryotomograms were recorded using TEMography
(JEOL, USA) at 200 kV with a JEOL JEM 2200FS equipped with a U filter. A
10 eV energy window was used to record Z-loss filtered images. Cryotomo-
grams were collected at 1.5 increments over 100 range at 25,0003magnifi-
cation. Images were recorded at 5 to 7 mm underfocus, binning 1,
corresponding to 4 A˚/pixel using an Ultrascan 100 GATAN CCD camera.
The total dose was set to 80 electrons/A2. Tilt series alignment and weighted
back-projection reconstruction were performed with the aid of the gold beads
using etomo (IMOD) software. Reconstructed structures were computationally
identified with the isosurface selection tool in IMOD.
Image Analysis and Quantification
Melanosome stages were defined bymorphology (van Niel et al., 2011). Quan-
tification of the length and width of melanosomes was determined using the
iTEM software (Soft Imaging System [SIS]).
Antibodies list, siRNA list, exosome isolation on optiprep gradient, cell frac-
tionation, melanin assay, genotyping, immunofluorescence microscopy, pro-
teomic analysis, cell culture and SILAC labeling (metabolic labeling and
exosome purification), in-gel digestion, liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analysis, and processing of MS data are described
in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
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